Apocynin
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Apocynin
- DrugBank Accession Number
- DB12618
- Background
Acetovanillone has been used in trials studying the treatment of Bronchial Asthma and Chronic Obstructive Pulmonary Disease.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 166.1739
Monoisotopic: 166.062994186 - Chemical Formula
- C9H10O3
- Synonyms
- Acetovanillone
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group.
- Kingdom
- Organic compounds
- Super Class
- Organic oxygen compounds
- Class
- Organooxygen compounds
- Sub Class
- Carbonyl compounds
- Direct Parent
- Alkyl-phenylketones
- Alternative Parents
- Methoxyphenols / Acetophenones / Phenoxy compounds / Methoxybenzenes / Benzoyl derivatives / Aryl alkyl ketones / Anisoles / Alkyl aryl ethers / 1-hydroxy-2-unsubstituted benzenoids / Organic oxides show 1 more
- Substituents
- 1-hydroxy-2-unsubstituted benzenoid / Acetophenone / Alkyl aryl ether / Alkyl-phenylketone / Anisole / Aromatic homomonocyclic compound / Aryl alkyl ketone / Benzenoid / Benzoyl / Ether show 8 more
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- methyl ketone, aromatic ketone, acetophenones (CHEBI:2781) / Flavans, Flavanols and Leucoanthocyanidins (C11380)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- B6J7B9UDTR
- CAS number
- 498-02-2
- InChI Key
- DFYRUELUNQRZTB-UHFFFAOYSA-N
- InChI
- InChI=1S/C9H10O3/c1-6(10)7-3-4-8(11)9(5-7)12-2/h3-5,11H,1-2H3
- IUPAC Name
- 1-(4-hydroxy-3-methoxyphenyl)ethan-1-one
- SMILES
- COC1=C(O)C=CC(=C1)C(C)=O
References
- General References
- Not Available
- External Links
- KEGG Compound
- C11380
- PubChem Compound
- 2214
- PubChem Substance
- 347828831
- ChemSpider
- 21106900
- ChEBI
- 2781
- ChEMBL
- CHEMBL346919
- ZINC
- ZINC000000162515
- PDBe Ligand
- I75
- Wikipedia
- Apocynin
- PDB Entries
- 3tbc
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 1 Completed Basic Science Cardiovascular Disease (CVD) / Cardiovascular Risk / Vasoconstriction 2 1 Completed Basic Science Cardiovascular Disease (CVD) / Cardiovascular Risk / Vasodilation 1 1 Completed Treatment Bronchial Asthma 1 1 Completed Treatment Chronic Obstructive Pulmonary Disease (COPD) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 3.04 mg/mL ALOGPS logP 1.62 ALOGPS logP 1.07 Chemaxon logS -1.7 ALOGPS pKa (Strongest Acidic) 8.27 Chemaxon pKa (Strongest Basic) -4.9 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 46.53 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 44.9 m3·mol-1 Chemaxon Polarizability 16.94 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 141.0011379 predictedDarkChem Lite v0.1.0 [M-H]- 140.9519379 predictedDarkChem Lite v0.1.0 [M-H]- 134.87349 predictedDeepCCS 1.0 (2019) [M+H]+ 141.4323379 predictedDarkChem Lite v0.1.0 [M+H]+ 141.5194379 predictedDarkChem Lite v0.1.0 [M+H]+ 137.8784 predictedDeepCCS 1.0 (2019) [M+Na]+ 141.4947379 predictedDarkChem Lite v0.1.0 [M+Na]+ 146.82634 predictedDeepCCS 1.0 (2019)
Drug created at October 20, 2016 23:14 / Updated at June 12, 2020 16:53